期刊文献+

1186例HLA基因与白血病相关性分析研究 被引量:7

Associations of HLA Gene with Leukemia in 1186 Cases
下载PDF
导出
摘要 本研究探讨HLA-A、B、DRB1基因与3种常见白血病的相关性,采用序列特异性引物聚合酶链反应(polymerase chain reaction with sequence-specific primers,PCR-SSP)技术,对1186例的白血病患者(ALL 326例、AML 545例、CML 315例)进行HLA分型,与1234份健康非亲缘供者进行显著性比较,用Bonferroni校正法进行校正。结果表明:ALL患者组与对照组相比,HLA-DRB1*09的等位基因频率显著低于对照组(10.87%vs 16.08%;Pc=0.014,OR=0.637,95%CI=0.487-0.834);CML患者组与对照组相比,HLA-B*18的等位基因频率显著高于对照组(1.28%vs 0.20%;Pc=0.039,OR=6.336,95%CI=2.066-19.434)。某些HLA分子和白血病之间可能存在正相关和负相关。HLA-DRB1*09和ALL呈负相关表明,DRR1*09通过限制T细胞免疫反应在早期白血病性事件中起着重要作用;而HLA-B*18和CML呈正相关,提示B*18分子可能不主动呈递特异性白血病抗原,导致免疫逃逸。结论:本研究为临床对白血病的免疫治疗提供一些线索和思路。 The purpose of this study was to evaluate the potential associations between HLA-A, B, DRB1 gene and leukemia. A total of 1186 leukemic patients, including 326 patients with acute lymphoblastic leukemia (ALL), 545 patients with acute myeloid leukemia (AML), 315 patients with chronic myeloid leukemia (CML), and 1234 healthy unrelated donors were typed and were compared in a single centre by using same technique, then the Bonferroni correction method was used to correct the Type I error. The results indicated that as compared with the control, the frequency of HLA-DRB1 * 09 in ALL group significantly decreased ( 10.87 % versus 16.08 % ; Pc --0.014, OR = 0. 637, 95% CI = 0. 487 - 0. 834 ), while in compadsion with control, the frequency of HLA-B* 18 in CML group was significanly higher ( 1.28% vs 0. 20% ; Pc = 0. 039, OR = 6. 336, 95% CI = 2. 066 - 19. 434 ). The positive and negative relation may exist between certain HLA molecules and leukemia. The negative relation between HLA-DRB1 * 09 and ALL indicated that DRB1 * 09 might play an important role by a restricted T-cell immune response in the early leukemogenic events, whereas the positive relation between HLA-B * 18 and CML suggests that the B * 18 molecules may not actively present leukemia-specific antigens resulting in immune escape. It is concluded that these findings can contribute to developing more appropriate method in leukemic immunotherapy.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2014年第2期263-268,共6页 Journal of Experimental Hematology
基金 国家自然基金(81070427)
关键词 HLA基因 白血病 免疫治疗 HLA gene leukemia immunotherapy
  • 相关文献

参考文献19

  • 1Cai A, Keskin DB, DeLuca DS, et al. Mutated BCR-ABL generates immunogenie T-cell epitopes in CML patients. C|in Cancer Res, 2012 , 18 ( 20 ) :5761 - 5772.
  • 2Rezvani K, Yong AS, Tawab A, et al. Ex vivo characterization of polyclonal memory CD8 + T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia. Blood, 2009 , 113 ( 10 ) : 2245 - 2255.
  • 3AI Qudaihi G, Lehe C, Dickinson A, et al. Identification of a novel peptide derived from the M-phase phosphoprotein 11 (MPP11 ) leukemic antigen recognized by human CD8+ cytotoxic T lymphocytes. Hematol Oncol Stem Cell Ther,2010,3 ( 1 ) :24 - 33.
  • 4Bortin MM, D'Amaro J, Bach FH, et al. HLA associations with leukemia. Blood, 1987 ,70 ( 1 ) :227 - 232.
  • 5Niens M, Jarrett RF, Hepkema B, et al. HLA-A * 02 is associated with a reduced risk and HLA-A * 01 with an increased risk of developing EBV ~ Hodgkin lymphoma. Blood, 2007 , 110 ( 9 ) : 3310 -3315.
  • 6Posthuma EF, Falkenburg JH, Apperley JF, et al. HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMT. Blood, 1999 ,93 ( 11 ) : 3863 - 3865.
  • 7Posthuma EF, Falkenburg JH, Apperley JF, et al. HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry. Leukemia, 2000 : 14 (5) : 859 - 862.
  • 8Garcia-Lora A, Algarra I, Garrido F. MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol, 2003 , 195 ( 3 ) : 346 - 355.
  • 9Miao KR, Pan QQ, Xue M, et al. Human leukocyte antigens in 295 Chinese patients with chronic myeloid leukemia. Leuk Lymphoma, 2007 ,48( 11 ) :2152 -2156.
  • 10Yari F, Sobhani M, Sabaghi F, et al. Frequencies of HLA-DRB 1 in Iranian normal population and in patients with acute lymphoblastic leukemia. Arch Med Res, 2008 ,39 ( 2 ) :205 - 208.

二级参考文献22

  • 1吴国光,邓志辉,高素青,程良红,金士正,周丹,李桢,邹红岩,张旋,魏天莉,程曦,王大明.6965名汉族骨髓供者HLA多态性分析[J].中华血液学杂志,2004,25(8):473-477. 被引量:96
  • 2Marsh SG, Albert ED. Bodmer WF, et al. Nomenclature for factors of the HLA system,2002: Tissue Antigens, 2002; 60:407 - 464
  • 3Rigas B. HLA and Disease Association: the case and gastric cancer.Gastroenterology, 1996,111:523 - 526
  • 4Klitz W. Immunogenetics. Viruses, cancer and the MHC. Nature,1992; 356:17 - 18.
  • 5Posthuma EF, Falkenburg JH, Apperley JF, et al. HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. Blood, 1999; 93:3863 - 3865.
  • 6Hester JP, Rossen R, Trujillo J, et al. Frequency of HLA antigens in chronic myelocytic leukemia. South Med J, 1977; 70: 691 - 693.
  • 7Bortin MM, D'Amaro J, Bach FH, et al. HLA associations with leukemia. Blood, 1987; 70:227 - 232.
  • 8Terasaki P, David G. HLA 1997. California USA: UCLA Tissue Typing Lab. 1997:213 -3122005;13(4):567-569.
  • 9Bortin MM, D'Amaro J, Bach FH, et al. HLA associations with leukemia. Blood, 1987,70:227-232.
  • 10Saunthararajah Y, Nakamura R, Nam JM, et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood, 2002, 100 : 1570-1574.

共引文献30

同被引文献32

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部